Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:nonprofit_organization
|
| gptkbp:advocatesFor |
evidence-based drug policy
|
| gptkbp:collaboratesWith |
gptkb:Imperial_College_London
gptkb:Maastricht_University |
| gptkbp:focusesOn |
psychedelic research
drug policy reform |
| gptkbp:foundedBy |
gptkb:Amanda_Feilding
|
| gptkbp:foundedYear |
1998
|
| gptkbp:headquartersLocation |
gptkb:Oxford,_United_Kingdom
|
| gptkbp:mission |
to improve global drug policy and advance scientific understanding of psychoactive substances
|
| gptkbp:notableProject |
Beckley/Imperial Research Programme
Beckley/Maastricht Microdosing Research Programme |
| gptkbp:studiedBy |
gptkb:ayahuasca
gptkb:LSD cannabis psilocybin |
| gptkbp:website |
https://www.beckleyfoundation.org/
|
| gptkbp:bfsParent |
gptkb:Amanda_Feilding
gptkb:Breaking_Convention gptkb:Beckley_Psytech |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Beckley Foundation
|